The case for SABR as the global standard for non-operable early-stage non-small cell lung cancer

Autor: Mutsaers, Adam, Louie, Alexander V., Ynoe Moraes, Fabio
Zdroj: In The Lancet Regional Health - Americas October 2022 14
Databáze: ScienceDirect